• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY ORTHOPAEDICS INC US 12/14 ARTICUL 40MM M SPEC+12; ARTICULEZE HEAD (12/14 TAPER) : HIP METAL FEMORAL HEADS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY ORTHOPAEDICS INC US 12/14 ARTICUL 40MM M SPEC+12; ARTICULEZE HEAD (12/14 TAPER) : HIP METAL FEMORAL HEADS Back to Search Results
Model Number 1365-08-000
Medical Device Problem Code Naturally Worn (2988)
Health Effect - Clinical Codes Adhesion(s) (1695); Foreign Body Reaction (1868); Pain (1994); Osteolysis (2377); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 08/10/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Pcf and medical records received.After review of medical records patient was revised to addressed pain, metallosis debris in the joint, elevated metal ions levels, scar in pseudocapsule, some lysis in the area of the trochanter and area of anterior-superior wall of the cup.Cup was removed with minimal bone loss and was in retroverted position.Doi: (b)(6) 2008 dor: (b)(6) 2020 right hip.(b)(4).
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot: a (mre) review will not be performed even when product/lot information is known.Per (b)(4), it has been determined that should related reports be identified an mre is not required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
12/14 ARTICUL 40MM M SPEC+12
Common Device Name
ARTICULEZE HEAD (12/14 TAPER) : HIP METAL FEMORAL HEADS
Manufacturer (Section D)
DEPUY ORTHOPAEDICS INC US
700 orthopaedic drive
warsaw IN 46581 0988
MDR Report Key11021541
Report Number1818910-2020-27108
Device Sequence Number17208452
Product Code JDI
UDI-Device Identifier10603295033028
UDI-Public10603295033028
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K060031
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2008
Device Explanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 12/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/30/2013
Device Model Number1365-08-000
Device Catalogue Number136508000
Device Lot Number2707857
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 12/08/2020
Supplement Date Received by Manufacturer01/21/2021
Initial Report FDA Received Date12/16/2020
Supplement Report FDA Received Date01/22/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
12/14 ARTICUL 40MM M SPEC+12; CORAIL2 STD SIZE 14; PINNACLE MTL INS NEUT40IDX56OD; PINNACLE SECTOR II CUP 56MM; 12/14 ARTICUL 40MM M SPEC+12; CORAIL2 STD SIZE 14; PINNACLE MTL INS NEUT40IDX56OD; PINNACLE SECTOR II CUP 56MM
Outcome Attributed to Adverse Event Required Intervention;
Patient Age82 YR
-
-